Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age-Reference-Cited by-同舟云学术

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age

Published:2019-05 Issue:10 Volume:12 Page:983-992
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Joyce Lauren C.,Baber Usman,Claessen Bimmer E.,Sartori Samantha,Chandrasekhar Jaya,Cohen David J.,Henry Timothy D.,Ariti Cono,Dangas George,Faggioni Michela,Aoi Shunsuke,Gibson C. Michael,Aquino Melissa,Krucoff Mitchell W.,Vogel Birgit,Moliterno David J.,Sorrentino Sabato,Colombo Antonio,Chieffo Alaide,Kini Annapoorna,Guedeney Paul,Witzenbichler Bernhard,Weisz Giora,Steg Philippe Gabriel,Pocock Stuart,Mehran Roxana

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Trends in U.S. cardiovascular care: 2016 report from 4 ACC national cardiovascular data registries;Masoudi;J Am Coll Cardiol,2017

2. What to expect from the evolving field of geriatric cardiology;Bell;J Am Coll Cardiol,2015

3. Geriatric cardiology: an emerging discipline;Dodson;Can J Cardiol,2016

4. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

5. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions;Journal of Clinical Medicine;2023-11-28

2. Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents;Circulation Research;2023-02-03

3. Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study;IJC Heart & Vasculature;2022-10

4. Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study;Cardiovascular Revascularization Medicine;2022-08

5. Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?;European Heart Journal;2022-03-17